InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Dubin Glenn, Director. Insider active across 1 companies, notably C4 Therapeutics, Inc.. In total, 7 reports have been recorded. The latest transaction was filed on 4 April 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
€9,137379 shares@ €24.10740.0049% mcap22.0% of flow
Common Stock
SEC:0001209191-22-023021:0·
€5,560199 shares@ €27.94140.0030% mcap34.4% of flow
Common Stock
SEC:0001209191-22-003502·
€5,560199 shares@ €27.94140.0030% mcap13.4% of flow
Common Stock
SEC:0001209191-22-003502:0·
€5,344138 shares@ €38.72290.0029% mcap33.1% of flow
Common Stock
SEC:0001209191-21-059526·
€5,344138 shares@ €38.72290.0029% mcap12.9% of flow
Common Stock
SEC:0001209191-21-059526:0·
€5,264157 shares@ €33.52960.0028% mcap32.6% of flow
Common Stock
SEC:0001209191-21-052780·
€5,264157 shares@ €33.52960.0028% mcap12.7% of flow
Common Stock
SEC:0001209191-21-052780:0·
7 of 7 declarations
About Dubin Glenn
Glenn Dubin is a Board Member at C4 Therapeutics, Inc. As a board member, he participates in the governance of the company and provides his expertise to guide strategic decisions. His experience in the biopharmaceutical sector is beneficial for C4 Therapeutics.
